Works matching IS 02724391 AND DT 2023 AND VI 84 AND IP 1

Results: 11

Multitargeted C9‐substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokinetics.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 121, doi. 10.1002/ddr.22017

By:

Raghuvanshi, Rinky;
Jamwal, Ashiya;
Nandi, Utpal;
Bharate, Sandip B.

Publication type:

Article

Discovery of pyrazole‐carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti‐tumor candidates.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 110, doi. 10.1002/ddr.22016

By:

Man, Ruo‐Jun;
Lu, Tian;
Zheng, Chi‐Chong;
Li, Tong;
Wu, Meng‐Ke;
Li, Dong‐Dong;
He, Xue‐Mei

Publication type:

Article

Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 96, doi. 10.1002/ddr.22015

By:

Chakraborty, Shuvechha;
Rahate, Kshitija;
Kumar, Chandan;
Idicula‐Thomas, Susan

Publication type:

Article

Labdane conjugates protect cardiomyocytes from doxorubicin‐induced cardiotoxicity.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 84, doi. 10.1002/ddr.22014

By:

Cuadrado, Irene;
Oramas‐Royo, Sandra;
González‐Cofrade, Laura;
Amesty, Ángel;
Hortelano, Sonsoles;
Estévez‐Braun, Ana;
de las Heras, Beatriz

Publication type:

Article

Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cells.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 75, doi. 10.1002/ddr.22013

By:

Ando‐Matsuoka, Rie;
Yagi, Kenta;
Takaoka, Mayu;
Sakajiri, Yuko;
Shibata, Tomokazu;
Sawada, Ryusuke;
Maruo, Akinori;
Miyata, Koji;
Aizawa, Fuka;
Hamano, Hirofumi;
Niimura, Takahiro;
Izawa‐Ishizawa, Yuki;
Goda, Mitsuhiro;
Sakaguchi, Satoshi;
Zamami, Yoshito;
Yamanishi, Yoshihiro;
Ishizawa, Keisuke

Publication type:

Article

Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 62, doi. 10.1002/ddr.22012

By:

Haney, Staci L.;
Feng, Dan;
Chhonker, Yashpal S.;
Varney, Michelle L.;
Williams, Jacob T.;
Smith, Lynette M.;
Ford, James B.;
Murry, Daryl J.;
Holstein, Sarah A.

Publication type:

Article

Novel Vanillin‐based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 45, doi. 10.1002/ddr.22011

By:

Dua, Tamanna;
Mangal, Surabhi;
Akshita, Goel;
Harshdeep;
Atri, Ankit K.;
Sharma, Purshotam;
Harjai, Kusum;
Singh, Vasundhara

Publication type:

Article

Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 36, doi. 10.1002/ddr.22010

By:

Liu, Zhiguang;
Zhu, Xiaochun;
Xu, Chenglin;
Min, Feng;
Yu, Guofeng;
Chen, Chuhong

Publication type:

Article

Dioscin induces osteosarcoma cell apoptosis by upregulating ROS‐mediated P38 MAPK signaling.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 25, doi. 10.1002/ddr.22009

By:

Zheng, Gui‐zhou;
Zhang, Qi‐hao;
Chang, Bo;
Xie, Peng;
Liao, Hang;
Du, Shi‐xin;
Li, Xue‐dong

Publication type:

Article

In vitro enzymatic evaluation of some pyrazolo[1,5‐a]pyrimidine derivatives: Design, synthesis, antioxidant, anti‐diabetic, anti‐Alzheimer, and anti‐arthritic activities with molecular modeling simulation.

Published in:

Drug Development Research, 2023, v. 84, n. 1, p. 3, doi. 10.1002/ddr.22008

By:

Hassan, Ashraf S.;
Morsy, Nesrin M.;
Aboulthana, Wael M.;
Ragab, Ahmed

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2023, v. 84, n. 1, p. 1, doi. 10.1002/ddr.21943
Publication type:: Article